Skip to main content
Heart logoLink to Heart
. 2000 Sep;84(Suppl 1):i48–i49. doi: 10.1136/heart.84.suppl_1.i48

The future: cardiovascular medicine in 10 years

K Swedberg
PMCID: PMC1766528  PMID: 10956324

Full Text

The Full Text of this article is available as a PDF (79.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baigent C., Collins R., Appleby P., Parish S., Sleight P., Peto R. ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither. The ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. BMJ. 1998 May 2;316(7141):1337–1343. doi: 10.1136/bmj.316.7141.1337. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Pitt B., Poole-Wilson P. A., Segal R., Martinez F. A., Dickstein K., Camm A. J., Konstam M. A., Riegger G., Klinger G. H., Neaton J. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II. Lancet. 2000 May 6;355(9215):1582–1587. doi: 10.1016/s0140-6736(00)02213-3. [DOI] [PubMed] [Google Scholar]

Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES